Lv11
24 积分 2023-09-11 加入
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα
4小时前
待确认
Dual PI3K/mTOR inhibition is required to combat resistance to CDK4/6 inhibitor and endocrine therapy in PIK3CA -mutant breast cancer
4小时前
已完结
Lessons learned in linking PROTACs from discovery to the clinic
4小时前
已完结
Cathepsins: Emerging targets in the tumor ecosystem to overcome cancers
1个月前
已完结
Thrombospondin 1 and Its Mimetic Peptide ABT-510 Decrease Angiogenesis and Inflammation in a Murine Model of Inflammatory Bowel Disease
1个月前
已完结
CD36: a promising therapeutic target in hematologic tumors
1个月前
已完结
CD36: a promising therapeutic target in hematologic tumors
1个月前
已完结
Thrombospondin 1 and Its Mimetic Peptide ABT-510 Decrease Angiogenesis and Inflammation in a Murine Model of Inflammatory Bowel Disease
1个月前
已完结
A phase I dose escalating study of the angiogenesis inhibitor thrombospondin-1 mimetic (abt-510) in patients with advanced cancer
1个月前
已完结
Preclinical Anti-Tumor Efficacy of ABT-510 (Thrombospondin-1 Mimetic Peptide), a Novel Anti-Angiogenic Agent, in Hematological Malignancies
1个月前
已关闭
皖公网安备34019202002308
